ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) traded up 4% during mid-day trading on Tuesday . The stock traded as high as $1.30 and last traded at $1.29. 33,981 shares were traded during trading, an increase of 67% from the average session volume of 20,327 shares. The stock had previously closed at $1.24.
ImmunoPrecise Antibodies Stock Up 4.0 %
The company’s fifty day moving average price is $1.69 and its 200-day moving average price is $1.58.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Recommended Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Silicon Motion Proves That AI in Motion Stays in Motion
- Profitably Trade Stocks at 52-Week Highs
- Undervalued UnitedHealth Group Won’t Be For Long
- Low PE Growth Stocks: Unlocking Investment Opportunities
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
